A detailed history of My Legacy Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, My Legacy Advisors, LLC holds 6,278 shares of ABBV stock, worth $1.22 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
6,278
Previous 6,092 3.05%
Holding current value
$1.22 Million
Previous $944,000 13.98%
% of portfolio
0.35%
Previous 0.34%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$154.79 - $180.76 $28,790 - $33,621
186 Added 3.05%
6,278 $1.08 Million
Q1 2024

Jul 25, 2024

SELL
$159.82 - $182.1 $26,530 - $30,228
-166 Reduced 2.64%
6,112 $1.11 Million
Q4 2023

Jan 12, 2024

BUY
$137.6 - $154.97 $309,187 - $348,217
2,247 Added 58.44%
6,092 $944,000
Q3 2023

Oct 20, 2023

BUY
$133.59 - $154.65 $20,840 - $24,125
156 Added 4.23%
3,845 $573,000
Q2 2023

Jul 14, 2023

BUY
$132.51 - $164.9 $165,107 - $205,465
1,246 Added 51.0%
3,689 $497,000
Q1 2023

Apr 11, 2023

BUY
$144.61 - $166.54 $353,282 - $406,857
2,443 New
2,443 $389,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track My Legacy Advisors, LLC Portfolio

Follow My Legacy Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of My Legacy Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on My Legacy Advisors, LLC with notifications on news.